What's New
Front Page
Help & Support: AFTD Quality of Life Grants Now Provide Better Benefits to People with FTD
AFTD’s Comstock Grant program, which offers modest financial assistance to people with FTD and their care partners, has…
People with Non-English First Language Have Delayed bvFTD Symptom Onset, Study Shows
Researchers at the University of Sydney discovered that Australians born overseas who spoke a first language other…
“I Vowed to Take Care of Him; Then He Filed for Divorce” – Article Shares Woman’s Tumultuous FTD Journey
In a recent article published on the website The Cut, author Katherine Nichols shares the tumultuous FTD…
Iowa Woman Discusses Her Genetic FTD Status in Fox News Interview
Alyssa Nash, a 27-year-old hospital receptionist, shared her experiences on the FTD journey and learning she carries…
Dr. Chiadi Onyike Named AFTD Medical Advisory Council Chair-Elect
During their annual meeting at the 2023 Education Conference, AFTD’s Board of Directors named Chiadi Onyike, MD,…
Guest Feature: “That Thin Thread Blooms into A Rainbow” – The FTD Journey from the LGBTQIA+ Perspective
The FTD journey is wrought with hardships, with families often facing a lengthy diagnostic process, steep costs…
Tips & Advice: Documenting Changing Behavior
Many behaviors caused by FTD, such as aggression, disinhibition, delusions, and apathy, are challenging and distressing for…
Advancing Hope: Accelerating Drug Discovery for FTD – New Awards From a Long-Standing Partnership
Before FTD researchers can initiate a clinical trial of a new medication, they must carry out preclinical…
Wave Life Sciences Ends FTD/ALS Trial of WVE-004
Yesterday, Wave Life Sciences announced that it ended its FOCUS-C9 clinical trial for the drug WVE-004, which…
Advancing Hope: Major Leaders in FTD and ALS Research Gather in Arizona for Summit on C9orf72 Gene
In March, prominent leaders in FTD and ALS research gathered in Scottsdale, Arizona, for the first-ever summit…